Related Experiment Video
Updated: Jan 8, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Beyond Menopause: Ending the Inequality-Why Men with Prostate Cancer Still Lack Therapies for Hot Flushes
Martino Pedrani1, Silke Gillessen1, Erik Briers2
1Istituto Oncologico della Svizzera Italiana, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Abstract:
Androgen deprivation therapy (ADT) causes hot flushes that can disrupt an individual's quality of life. NK3R antagonists provide rapid, sustained, and nonhormonal relief of hot flushes in women, but an approved treatment is lacking for men. Pragmatic trials are needed to generate evidence to support approval of these agents for the ADT setting.
Insights
Androgen deprivation therapy (ADT) causes hot flushes. NK3R antagonists offer relief for women, but men need approved treatments. Pragmatic trials are essential to support approval for men undergoing ADT.
Area of Science:
- Oncology
- Endocrinology
- Pharmacology
Background:
- Androgen deprivation therapy (ADT) is a common treatment for prostate cancer.
- Hot flushes are a frequent and disruptive side effect of ADT, significantly impacting patient quality of life.
- Current treatments for ADT-induced hot flushes in men are limited.
Related Concept Videos
Menopause
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Heart Failure VI: Adjunct Therapies

